- SENIOR FACULTY Medicine, Cardiology
Ronald Li, PhD, is a Senior Faculty in Cardiology at Mount Sinai School of Medicine. Dr. Li runs a lab within the School’s Cardiovascular Research Center, where he leads a program in cardiac stem cell engineering and electrophysiology. The program focuses on electrophysiology and construction of custom-tailored human heart cells.
The lab’s work on cardiac differentiation has been recognized by the American Heart Association as Best Basic Study of 2005, Ground-Breaking Study of 2006, and Late-Breaking Studies of 2003, 2004 and 2007. The lab receives funding from the National Institute of Health and the California Institute of Regenerative Medicine, among others.
Dr. Li concurrently runs the stem cell program at Hong Kong University. He has published more than 70 papers and has served as a panel member or reviewer for a number of funding agencies, including the National Institutes of Health, American Heart Association, Association Francaise contre les Myopathies, United States-Israel Binational Science Foundation, Research Grant Council of Hong Kong, Stem Cell Consortium, A*STAR/Biopolis of Singapore, Wellcome Trust, and MRC of the United Kingdom.
Before joining Mount Sinai, Dr. Li was a tenured associate professor at the University of California, Davis, with cross appointments in biomedical engineering, biophysics, genetics, physiology, and cell biology. During that time he led the Human Embryonic Stem Cell Consortium.
Dr. Li also served as an associate investigator of the Institute of Pediatric Regenerative Medicine at the Shriners Hospital for Children, adjunct associate professor of medicine at Hong Kong University, and assistant professor of medicine at the Johns Hopkins University.
2004 Top Junior Faculty Research Award, Johns Hopkins University Department of Medicine
2002 Top Junior Faculty Research Award, Johns Hopkins University Department of Medicine
2002 Young Investigator Award, Heart Rhythm Society
2001 Career Development Award, Cardiac Arrhythmias Research & Education Foundation
2001 Top Prize for Young Investigator Basic Research, Johns Hopkins University School of Medicine
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Li did not report having any of the following types of financial relationships with industry during 2012 and/or 2013: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.
Atran Berg Laboratory Building Floor 3rd Room 323
1428 Madison Avenue
New York, NY 10029